medtronic begins wide trial for stents medtronic inc said it has enrolled the first patient in a large randomized trial designed to study the safety of drug coated stent heart devices concerns about clots linked to stents have recently depressed the market for the tiny heart devices which prop open arteries and use medication to combat renarrowing boston scientific corp and johnson &amp johnson are the biggest stent makers but minneapolis based medtronic has a stent called endeavor it is selling overseas and hopes to bring to the u s this year pending regulatory approval endeavor has so far looked good from a safety standpoint in its trials the new patient study called protect will compare endeavor with the cypher stent made by j&amp j with the primary goal of measuring stent thrombosis or stent related clots at three years the study will enroll patients at centers world wide the patients will represent the people typically seen by doctors 
